Related Experiment Video
Updated: May 7, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Development and analytical validation of a targeted short-read next generation sequencing-based pharmacogenetic panel
Anna Gréen1, Nils Johan Fredriksson2, Michael Andresen3
1Department of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
A new pharmacogenetic test panel offers accurate, cost-effective genomic profiling for personalized medicine. This comprehensive assay translates genetic variants into drug dosage recommendations for safer and more effective treatments.
Area of Science:
- Pharmacogenomics
- Clinical Genetics
- Molecular Diagnostics
Background:
- Genomic profiling aids in predicting drug response and toxicity.
- Personalized medicine requires accurate identification of genetic variants affecting drug efficacy.
- Current methods like whole-genome sequencing can be expensive for widespread clinical use.
Purpose of the Study:
- To develop a comprehensive, high-quality pharmacogenetic test panel.
- To utilize a cost-effective technique compared to high-coverage whole-genome sequencing.
- To enable clinical application of pharmacogenetic testing.
Main Methods:
- Designed a targeted pan-pharmacogenomics (pan-PGx) panel using Twist probe capture.
- Applied Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines and aggregated data from PharmVar, PharmGKB, and IPD-IMGT/HLA.
- Utilized Illumina short-read sequencing and analysis tools including PharmCAT for variant calling and interpretation.
Main Results:
- The developed method demonstrated accuracy and suitability for large-scale clinical pharmacogene testing.
- Successfully identified single-nucleotide variants, InDels, structural/hybrid genes, and copy number variants.
- Generated actionable dose recommendations based on identified pharmacogenetic variants.
Conclusions:
- The pharmacogenetic assay is suitable for clinical implementation.
- Facilitates pharmacogenomic-guided drug treatments for improved patient outcomes.
More Related Videos
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
05:51A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
Published on: June 15, 2011
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Principles of Pharmacogenetics: Types of Genetic Variants
Pharmacogenetics of Drug Metabolism: Overview